Management Prospects for COVID-19: A Review




Although the number of active COVID-19 cases have been fallen in some countries, the threat of the pandemic is still impending in many parts of the world and the pace of recovery is still uncertain. SARS-CoV-2 outbreak has expanded very quickly since the beginning of 2020 and has now taken approximately a million lives all around the globe. Sadly, there is yet to be an approved treatment for COVID-19 as it may take a few years to establish a definitive treatment and a vaccine against SARS-CoV-2. This study aims to review the preventive and curative measures currently under investigation for COVID-19 and the targeted pathogenic features of the SARS-CoV-2. To manage the clinical implications of COVID-19, and to alleviate SARS-CoV-2, the main focus is on supportive therapy, symptom control, antiviral drugs, and immunomodulation. Intense research activities for therapeutic interventions are in progress worldwide to evaluate the benefit of such drugs.


Download data is not yet available.

Author Biographies

Uzma Aamir Jilani, Management & Science University

Postgraduate Biomedicine Research Student

Ishrat Rahman, Department of Basic Dental Sciences, College of Dentistry, Princess Nourah bint Abdulrahman University

Assistant Professor of Pharmacology




How to Cite

Jilani, U. A., Rahman, I., & Jilani, S. A. (2020). Management Prospects for COVID-19: A Review. Technium: Romanian Journal of Applied Sciences and Technology, 2(7), 118–127.